Yasin Şenbabaoğlu

Cited by

	All	Since 2019
Citations	35727	26631
h-index	31	28
i10-index	35	33

6000

3000

1500

4500

20142015201620172018201920202021202220232024299 979 1911 2464 3143 3808 4612 5726 5684 5146 1654

Public access

View all

29 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Chris SanderHarvard Medical School, Broad Institute, Dana-Farber Cancer Institute, Memorial Sloan KetteringVerified email at sanderlab.org
Ilya ShmulevichProfessor, Institute for Systems BiologyVerified email at systemsbiology.org
Gordon MillsOregon Health & Science UniversityVerified email at ohsu.edu
John N WeinsteinMD Anderson Cancer CenterVerified email at mdanderson.org
Martin L MillerSenior Director, AstraZenecaVerified email at astrazeneca.com
Giovanni CirielloDepartment of Computational Biology, University of Lausanne (UNIL)Verified email at unil.ch
Nikolaus SchultzCenter for Molecular Oncology, Memorial Sloan Kettering Cancer CenterVerified email at cbio.mskcc.org
Jun LiCaltech, Stanford (previously), Michigan (current)Verified email at med.umich.edu
George MichailidisProfessor of Statistics and Computer ScienceVerified email at ufl.edu
Alexis DesrichardMemorial Sloan Kettering Cancer InstituteVerified email at mskcc.org
Luc MorrisMSKCCVerified email at mskcc.org
Bulent Arman AksoyObsidian TherapeuticsVerified email at aksoy.org
Ed ReznikMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Allen TannenbaumDistinguished Professor, Computer Science/Applied Mathematics, Stony Brook UniversityVerified email at stonybrook.edu
William LeeMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Jonathan HavelVolastra TherapeuticsVerified email at volastratx.com
Vladimir MakarovВысшая школа экономики Verified email at hse.ru
Max WichaVerified email at umich.edu
Shawn G. ClouthierUniversity of MichiganVerified email at umich.edu
Khaled HassanCleveland ClinicVerified email at ccf.org

Yasin Şenbabaoğlu

Genentech

Verified email at gene.com

Computational Biology Cancer Immunology Data Mining Data Science


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
The Cancer Genome Atlas Pan-Cancer analysis project TCGA Network, JN Weinstein, EA Collisson, GB Mills, KRM Shaw, ... Nature Genetics 45 (10), 1113–1120, 2013	6399*	2013
Comprehensive molecular characterization of gastric adenocarcinoma TCGA Network Nature 513 (7517), 202-209, 2014	5083	2014
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells Mariathasan, Turley, Nickles, Castiglioni, Yuen, Wang, Kadel, Koeppen, ... Nature, 2018	3707	2018
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas Cancer Genome Atlas Research Network New England Journal of Medicine 372 (26), 2481-2498, 2015	2875	2015
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015	2654	2015
Integrated Genomic Characterization of Papillary Thyroid Carcinoma TCGA Network Cell 159 (3), p676-690, 2014	2482*	2014
Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020	1657*	2020
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. KA Hoadley, et al. Cell 158 (4), 929-44, 2014	1523	2014
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma TCGA Network Cancer Cell 32 (2), 185-203, 2017	1516	2017
Emerging landscape of oncogenic signatures across human cancers G Ciriello, ML Miller, BA Aksoy, Y Senbabaoglu, N Schultz, C Sander Nature genetics 45 (10), 1127-1133, 2013	1484	2013
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ... Nature, 2017	983	2017
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas TCGA Network Cell 171 (4), 950-965, 2017	789	2017
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures Y Şenbabaoğlu, RS Gejman, AG Winer, M Liu, EM Van Allen, ... Genome biology 17, 1-25, 2016	786	2016
The head and neck cancer immune landscape and its immunotherapeutic implications R Mandal, Y Senbabaoglu, A Desrichard, et al. JCI Insight 1 (17), 2016	673	2016
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15⁺ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy CX Dominguez, S Müller, S Keerthivasan, H Koeppen, J Hung, S Gierke, ... Cancer discovery 10 (2), 232-253, 2020	517	2020
Mitochondrial DNA copy number variation across human cancers E Reznik, M Miller, Y Şenbabaoğlu, N Riaz, J Sarungbam, S Tickoo, ... eLife 5 (e10769), 2016	450	2016
Multilevel genomics-based taxonomy of renal cell carcinoma F Chen, Y Zhang, Y Şenbabaoğlu, G Ciriello, L Yang, E Reznik, B Shuch, ... Cell reports 14 (10), 2476-2489, 2016	339	2016
Critical limitations of consensus clustering in class discovery Y Senbabaoglu, G Michailidis, JZ Li Scientific Reports 4, 2014	302	2014
Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival L Morris, N Riaz, A Desrichard, Y Şenbabaoğlu, A Hakimi, V Makarov, ... Oncotarget, 2016	289	2016
CTLA-4 blockade drives loss of T_reg stability in glycolysis-low tumours R Zappasodi, I Serganova, IJ Cohen, M Maeda, M Shindo, ... Nature 591 (7851), 652-658, 2021	226	2021

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors